Evidence map›Paper›PMID 41723554›Full record

ArticleAdvances in rheumatology (London, England)2026

Incidence, prevalence and clinical features of systemic sclerosis patients from a southern Brazilian city.

Alana Rubia Balbinot, Letícia de Abreu Wiedmer de Siqueira, Poliana Vieira da Silva Menolli, Rafael Andrade Menolli, Ana Paula Adame

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in rheumatology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alana Rubia BalbinotPostGraduate Program in Dentistry, Center of Biological and Health Sciences, Western Parana State University, Cascavel, PR, Brazil.ORCID http://orcid.org/0000-0003-0972-4139
Letícia de Abreu Wiedmer de SiqueiraWestern Parana University Hospital, Western Parana State University, Cascavel, PR, Brazil.ORCID http://orcid.org/0000-0002-7900-3874
Poliana Vieira da Silva MenolliCenter of Medical and Pharmaceutical Sciences, Western Parana State University, 2069 Universitaria st, Cascavel, PR, CEP 85819-110, Brazil.ORCID http://orcid.org/0000-0001-9741-1049
Rafael Andrade MenolliPostGraduate Program in Dentistry, Center of Biological and Health Sciences, Western Parana State University, Cascavel, PR, Brazil. rafael.menolli@unioeste.br.ORCID http://orcid.org/0000-0003-2728-8318
Ana Paula AdameWestern Parana University Hospital, Western Parana State University, Cascavel, PR, Brazil.ORCID http://orcid.org/0000-0001-6903-6712

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSystemic sclerosis (SSc) is a chronic and heterogeneous disorder characterized by vascular, inflammatory, and fibrotic changes in the skin and internal organs. As epidemiological studies on SSc in Brazil are few, most reports are from international literature. This study aimed to determine the incidence, prevalence, clinical and laboratory characteristics, and therapeutic management of patients diagnosed with SSc in Cascavel, a southern Brazilian city. Methods: Cross-sectional study that collected data from all rheumatology services in the city (six private rheumatology clinics, a regional specialty center, a municipal specialty center, and an outpatient clinic at a university hospital) in 2020. After the epidemiological survey, eligible patients were invited to undergo investigation for possible orofacial manifestations. Results: We identified 57 patients who were treated for SSc in clinics, 30 of whom lived in Cascavel, Brazil. The estimated prevalence of SSc was 9 ± 0.03 cases/100,000 population, and the incidence in 2020 was 1.2 ± 0.004 cases/100,000 population. Most patients were female, and the mean age at diagnosis was 42.5 ± 17.22 years. The most frequently reported clinical feature is Raynaud’s phenomenon, followed by skin thickening. Limited SSc was the SSc syndrome most frequently identified by physicians, and the antinuclear antibody test was positive in 86.66% of the patients. Six patients participated in the orofacial alteration investigation. Half of the patients had very low hyposalivation, and all had telangiectasias and periodontal disease. Conclusions: Clinical and epidemiological data from Cascavel, Brazil corroborate the findings of previous studies. Orofacial compromise was common in patients with SSc. Increased awareness among healthcare teams managing these patients is necessary to evaluate and manage orofacial problems.

Indexed as

Scleroderma, SystemicAdolescentAdultAgedBrazilCross-Sectional StudiesFemaleHumansIncidenceMaleMiddle AgedPrevalenceRaynaud DiseaseYoung AdultIncidenceOral manifestationsPrevalenceSystemic sclerosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.